Insights On Regulatory Compliance
-
Analytical Strategies For Impurity Control In Antibody-Drug Conjugates
7/16/2025
Antibody-drug conjugates (ADCs) combine antibody targeting with potent cytotoxic payloads to treat resistant cancers, but their complexity requires phase-appropriate analytical strategies.
-
Viral Disinfectant Efficacy Studies: Key Guiding Factors And Design Elements
4/8/2025
Achieving compliance and safety through Disinfectant Efficacy Studies (DES) is about adhering to regulations and committing to high standards of safety and quality of manufacturing operations.
-
Tackling Residual DNA Testing In Biotherapy Manufacturing
7/16/2025
Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.
-
A Shift Towards Biofluorescent Particle Counters In Manufacturing
5/12/2025
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
-
Successful Microbial Testing And Identification
5/27/2025
In this presentation, one of our industry-leading customers discusses how they've successfully implemented the Applied Biosystems MicroSEQ Microbial Identification System in their laboratory testing.
-
The Unintended Consequences Of The Inflation Reduction Act (IRA)
10/21/2024
Cencora PayerPulse provides insights into market access trends and the Inflation Reduction Act's impact on Medicare Part D, based on research from 41 advisors.
-
What Is The Position Of Regulatory Authorities On PUPSIT?
5/2/2025
PUPSIT and other integrity testing methods are crucial for manufacturers to reduce contamination risks and ensure drug product safety. Learn how your company can adhere to updated regulatory guidelines.
-
The Benefits Of Automating Your Requirements Traceability Matrix
7/23/2025
The Requirements Traceability Matrix ensures every system requirement is verified through testing, supporting compliance, reducing risk, and strengthening validation efforts across development.
-
How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions
8/11/2025
With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence
-
The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly
3/3/2025
In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.